A Randomized, Evaluator-Blinded, Parallel Group Comparison of PDT With Levulan Topical Solution + Blue Light vs Levulan Topical Solution Vehicle + Blue Light for the Treatment of AK and Reduction of New NMSC in Organ Transplant Recipients.
Phase of Trial: Phase II
Latest Information Update: 20 Oct 2011
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Actinic keratosis; Skin cancer
- Focus Therapeutic Use
- 20 Oct 2011 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 12 Nov 2010 Planned End Date changed from 1 Sep 2010 to 1 Sep 2011 as reported by ClinicalTrials.gov.
- 12 Nov 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.